| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |